Mitsukazu Gotoh

1.0k citations
30 papers · 820 indexed · h-index 18
Topics
Immunotherapy and Immune Responses (4 papers)Cancer Immunotherapy and Biomarkers (4 papers)RNA modifications and cancer (4 papers)
Partner nations
JapanGermany

In The Last Decade

Mitsukazu Gotoh

30 papers receiving 804 citations

Peers

Mitsukazu Gotoh
Comparison fields: 5 of 71
  • Molecular Biology 365
  • Oncology 300
  • Cancer Research 275
  • Surgery 187
  • Immunology 150
Replace Juling Ji with:
Juling Ji China
So Mee Kwon South Korea
Joanna W. Ho Hong Kong
Zhi Dai China
Rongfa Yuan China
Larry Lai Wei Hong Kong
Hiroaki Kasashima Japan
Chun Sun China
Stefan Grotegut United States
Su-Su Zheng China
Mitsukazu Gotoh relative to Juling Ji China Juling Ji's profile →
Citations per field
00.5×1.5×2.0×
Juling Ji · 1×
Citations per year

Countries citing papers authored by Mitsukazu Gotoh

Since Specialization
Citations

This map shows the geographic impact of Mitsukazu Gotoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsukazu Gotoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsukazu Gotoh more than expected).

Fields of papers citing papers by Mitsukazu Gotoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsukazu Gotoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsukazu Gotoh. The network helps show where Mitsukazu Gotoh may publish in the future.

Co-authorship network of co-authors of Mitsukazu Gotoh

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsukazu Gotoh. A scholar is included among the top collaborators of Mitsukazu Gotoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsukazu Gotoh. Mitsukazu Gotoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 53
3 40
4 19
5 42
6 14
7 38
8
[Myeloid-derived suppressor cells in cancer patients].
1
9 55
10 20
11 8
12 13
13
Development of the highly sensitive chemosensitivity testing using ATP bioluminescence assay
1
14 7
15 1
16 35
17 17
18 26
19 60
20 14

About Mitsukazu Gotoh

Mitsukazu Gotoh is a scholar working on Hepatology, Cancer Research and Immunology, having authored 30 papers that have together received 820 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (275 citations), Oncology (300 citations) and Hepatology (83 citations). Mitsukazu Gotoh has collaborated with scholars based in Japan and Germany. Frequent co-authors include Michihiko Kogure, Masanori Terashima, Morito Monden, Naoyuki Okabe, Hiroyuki Suzuki, Masato Sakon, Takumi Yamaura, Satoshi Muto, Jun Osugi and Mika Hoshino. Their work appears in journals such as Analytical Chemistry, Cancer Research and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026